Skip to main content

Table 3 Univariate and multivariate analyses for early recurrence in all cases (early vs no recurrence)

From: Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence

  Early vs no recurrence
  Univariate analysis p Value Multivariate analysis p Value
ALDH1, ≤1 %/>1 % 2.468 (1.438–4.274) 0.001 2.140 (1.149–4.003) 0.016
Bilateral breast cancer absent/present 14.156 (3.932–90.478) <0.001 16.434 (4.111–110.886) <0.001
Age, ≤50/>50 years 0.742 (0.513–1.073) 0.113 0.748 (0.490–1.142) 0.178
Tumor size ≤20/>20 mm 3.844 (2.604–5.745) <0.001 2.692 (1.747–4.181) <0.001
Nodal metastasis negative/positive 4.838 (3.220–7.336) <0.001 3.728 (2.383–5.876) <0.001
Tumor grade 1 or 2/3 2.615 (1.666–4.128) <0.001 2.063 (1.230–3.470) 0.006
Ki-67 staining <20 %/≥20 % 1.670 (1.076–2.586) 0.022 0.855 (0.506–1.427) 0.551
  1. ALDH1 aldehyde dehydrogenase 1